Refractory Follicular Lymphoma Diagnostics Market with Top 10 Companies & Size 2029
The Refractory Follicular Lymphoma (RFL) Diagnostics Market is poised for steady growth during the forecast period of 2025-2029, with a projected compound annual growth rate (CAGR) of 5.14%. In 2023, the market was valued at USD 345.81 million and is expected to reach USD 464.47 million by 2029, driven by advancements in diagnostic technologies and… Read More »